FOOD AND DRUG ADMINISTRATION
VACCINES AND
RELATED BIOLOGICAL PRODUCTS ADVISORY COMMITTEE
MEETING ON INFLUENZA VIRUS VACCINE FORMULATION FOR 2003-2004
MEETING BY TELECONFERENCE
Tuesday, March 18, 2003
Food and
Drug Administration
5515
Security Lane
Conference
Room A on the 11th Floor
Suite
1113, Rockville, MD
10:30 AM EST
10:30
AM Call to Order Dr. David Stephens, Committee Chair
10:35 Announcements
Dr. Jody Sachs, FDA
10:40 Open Session
Strain
Selection for the Influenza Virus Vaccine for 2003-2004
Introduction
and Review Dr.
Levandowski, FDA
Additional
Information, H3N2 Dr. Nancy Cox, CDC
11:10 Committee
Discussion Dr. Levandowski, FDA
11:30 Open Public
Hearing
12:30 Recommendations
for Influenza Virus Vaccine for 2003-2004
12:45 Adjournment